The Impact of Beef on Muscle Fatigue in Older Adults
The Effect of Beta-Alanine and Carnosine From Beef Intake on Muscle Fatigue in Older Adults
1 other identifier
interventional
24
1 country
1
Brief Summary
The goal of this controlled-feeding cross-over diet intervention is to compare a beef diet to a vegetarian diet on muscle fatigue in older adults. The aims are: AIM 1: To test the hypothesis that muscle fatigue is attenuated in older adults consuming beef compared to older adults consuming a plant-based diet. AIM2: To test the hypothesis that daily beef consumption improves biochemical indicators related to muscle fatigue. Participants will be randomized to consume either a beef-based diet or vegetarian diet under controlled-feeding conditions for 8 weeks. After a 2-week washout period, participants will cross-over to consume either the beef diet or vegetarian diet for 8 weeks. Body composition and functional muscle outcomes will be measured during each 8-week feeding period. Blood samples will also be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2023
CompletedFirst Posted
Study publicly available on registry
May 16, 2023
CompletedStudy Start
First participant enrolled
July 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2025
CompletedMay 1, 2026
April 1, 2026
2.4 years
April 25, 2023
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Sit-to-Stand Chair Test
The change in muscle strength observed in each diet condition will be evaluated through the Sit-To-Stand Chair Test. The number of times a participant comes to a full standing position (from a seated position) in 60 seconds will be recorded.
Weeks 0, 4, 8
Change in 6-minute walk
The change in muscle strength observed in each diet condition will be evaluated through the 6-Minute-Walk-Test. The distance walked by a participant during the 6 minute test period will be recorded.
Weeks 0, 4, 8
Retention of Participants
The percentage of randomized participants completing the 16-week diet intervention trial.
Through study completion, approximately 16 weeks
Adherence to Study Diets
Participant adherence to the study diets will be evaluated.
Through study completion, approximately 16 weeks
Secondary Outcomes (4)
Change in Lactate
Weeks 0, 4, 8
Change in Beta-Alanine
Weeks 0, 4, 8
Change in Carnosine
Weeks 0, 4, 8
Change in Amino Acids
Weeks 0, 4, 8
Study Arms (2)
Beef Diet
EXPERIMENTALParticipants will be randomized to consume the beef diet for 8 weeks. After a 2-week period, participants will cross-over to consume the vegetarian diet for 8 weeks.
Vegetarian Diet
EXPERIMENTALParticipants will be randomized to consume the vegetarian diet for 8 weeks. After a 2-week period, participants will cross-over to consume the beef diet for 8 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Ages 60-85 years
- Ability to eat study diet meals for a total of 16 weeks
- Ability to perform sit-to-stand chair and 6-minute walking tests based on results from PAR-Q questionnaire
- Ability to provide fasted blood samples
- Access to transportation
- Willing to abstain from alcohol consumption and/or use illicit drug use for each 8-week intervention period
- Ability to consent to participating in this study
- English-speaking
- Body mass index between 18.5 (normal) and 39.9 (obese) kg/m2
- Minimum total body weight of 110 pounds
- Non-anemia hemoglobin values: Females - \>12.0 grams/dL; Men - \>13.0 grams/dL
- Able to ambulate without assistance
- Physician's clearance for study participation (required prior to baseline testing)
You may not qualify if:
- Inability or refusal to sign the informed consent
- Significant orthopedic limitations or other contraindications to exercise
- Inability or refusal to perform muscle fatigue tests
- Has dietary restrictions that prevent to consumption of beef, soy and/or wheat
- Has liver or kidney complications
- Live or work \>25 miles from Bloomington study site or does not have transportation to the study site
- Anticipate elective surgery during the study period
- Diagnosis of progressive neurological disorders, musculoskeletal disorders, osteoarthritis, rheumatoid arthritis
- Fracture or serious injury in the last 6 months
- Stroke, revascularization, deep vein thrombosis, or pulmonary embolism in the past 12 months
- Severe cardiovascular disease, uncontrolled systemic hypertension, chronic pulmonary disease
- Plan to move residence or travel out of the local area during the study period
- Current use of anti-coagulants (e.g. Coumadin or Warfarin)
- Current use of prescription medications that affect heart rate or blood vessel dilation
- Psychological or social characteristics that would interfere with their ability to fully participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University Bloomington
Bloomington, Indiana, 47405, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cydne A Perry, PhD
Indiana University, Bloomington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Applied Health Sciences
Study Record Dates
First Submitted
April 25, 2023
First Posted
May 16, 2023
Study Start
July 10, 2023
Primary Completion
November 21, 2025
Study Completion
November 21, 2025
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share